Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
Goldhaber
Samuel Z
SZ
D016588:Anticarcinogenic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000517:prevention & control*; D005260:Female; D006801:Humans; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects* / Q000627:therapeutic use; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000453:epidemiology* / Q000209:etiology
D016588:Anticarcinogenic Agents; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen